ALAB
The pre-earnings caffeine rush
Astera Labs is having one of those classic “nothing has happened yet, but everyone is acting like it already did” days. Shares of the semiconductor connectivity company were up 8.57% to $218.50 on Tuesday as traders crowded in ahead of its first-quarter 2026 earnings report, which lands after the market closes.
Why investors are suddenly obsessed
The stock has become a momentum magnet. Wall Street is looking for 49 cents a share in earnings and $292.36 million in revenue, and the market clearly thinks Astera can keep its streak alive — it’s beaten EPS estimates in eight straight quarters.
That kind of consistency is catnip for investors. It turns every earnings print into a mini referendum: is this still a premium growth story, or is the market about to remember that even hot stocks can trip over their own shoelaces?
Shorts are backing off, too
There’s also less bearish pressure in the tape. Short interest dropped from 15.50 million shares to 14.44 million in the latest period, leaving about 11.11% of the float still sold short.
Translation: some skeptics are trimming their bets, which can add fuel when a stock is already moving fast. And right now ALAB is trading well above its key moving averages, so the chart crowd is basically saying, “this thing has legs, but don’t ask us how long the runways on this runway are.”
Big picture
For investors, the whole setup boils down to one question: can Astera Labs keep outperforming without the stock price outrunning reality? If the answer is yes, this breakout could get a second act. If not, the post-earnings hangover could be real.